Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries

The advent of biologics and biologic therapy has transformed the management of inflammatory bowel disease (IBD) with enhanced early and adequate responses to treatment, fewer hospitalizations, a reduced need for surgery, and unprecedented outcomes including complete mucosal and histologic healing. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Rupa, Ali, Raja Affendi Raja, Wei, Shu Chen, Adsul, Shashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667923/
https://www.ncbi.nlm.nih.gov/pubmed/33191310
http://dx.doi.org/10.5009/gnl19209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667923/
https://www.ncbi.nlm.nih.gov/pubmed/33191310
http://dx.doi.org/10.5009/gnl19209

Ejemplares similares